TerminatedNCT04525534

Plasma Concentration of Biological Markers in Placenta Accreta Spectrum

Studying Placenta accreta spectrum disorder

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Arkansas
Principal Investigator
Nadir e Sharawi, MD
UAMS
Intervention
There is no other intervention, only clinical treatment.(other)
Enrollment
19 target
Eligibility
18-45 years · FEMALE
Timeline
2020 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04525534 on ClinicalTrials.gov

Other trials for Placenta accreta spectrum disorder

Additional recruiting or active studies for the same condition.

See all trials for Placenta accreta spectrum disorder →

← Back to all trials